Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Asarfi Hospital Ltd.
Source DateBoard Meeting DateDetails
02-Feb-2026 09-Feb-2026 Quarterly Results
10-Nov-2025 10-Nov-2025 543943 | Board Meeting Outcome for Outcome Of The Board Meeting Held On November 10, 2025 And Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30,2025 Others 8.62 MB XBRLWe wish to inform you that the Board of Directors of Asarfi Hospital Limited (the Company), at its meeting held today, i.e., November 10, 2025, has considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025
12-Aug-2025 20-Aug-2025 A.G.M. Inter alia, to consider and approve:- 1) The Chairman to announce the quorum for the meeting. 2) To grant leave of absence to the director. 3) To note the minutes of the previous meeting. 4) Approval of the Directors Report for the year ending on March 31St 2025. 5) To appoint a director in place of Mrs. Madhuri Singh (DIN: 06562038) who retires by rotation and being eligible offers himself for re-appointment. 6) To appoint Ritu Ritolia & C0. (Firm COP No.: 8901), Practicing Company Secretary, Dhanbad as the Secretarial Auditor of the Company to hold office for a period of 5 (Five) consecutive financial years, commencing from financial year 2025-26 till financial year 2029-30. 7) To hold 20th Annual General Meeting (AGM) of the Company on Friday, September 12, 2025 at 12:00 Noon at the registered office of the Company. 8) To approve the book Closure dates for the purpose of AGM of the Company from September 06, 2025 to September 12, 2025 (both days inclusive). 9) Notice of the Annual General Meeting of the Company along with the Director s Report for circulation to members. 10) To Appoint Scrutinizer for the purpose of E-Voting and through Poll at the 20th Annual General Meeting of the Company. 11) Any other matter with the permission of Chairman.
31-Jul-2025 07-Aug-2025 Quarterly Results
05-May-2025 08-May-2025 Audited Results
23-Jan-2025 31-Jan-2025 Quarterly Results
22-Oct-2024 30-Oct-2024 Half Yearly Results
13-Aug-2024 20-Aug-2024 A.G.M.
30-Apr-2024 06-May-2024 Audited Results
06-Nov-2023 13-Nov-2023 Half Yearly Results
11-Aug-2023 19-Aug-2023 A.G.M. & Inter alia, to consider and approve:- 1. To hold 18th Annual General Meeting (AGM) of the Company on Friday, September 15, 2023, at 12:00 Noon at the registered office of the Company. 2. To approve the book Closure dates for the purpose of AGM of the Company from September 09th, 2023 to September 15th 12023 (both days inclusive). 3. Notice of the Annual General Meeting 4. Acceptance of resignation letter of Statutory Auditor D. N. Dokania & Associates (FRN: 050042C) Chartered Accountant. 5. Appointment of M/s R K Thakkar & Co. (FRN: 002690C), Chartered Accountant to fill the casual vacancy subject to the approval of members in the General Meeting. 6. Regularization of Mr. Gopal Singh (DIN: 01608342) as Executive Director of the Company subject t the approval of members. 7. Increase in Remuneration of Mr. Udai Pratap Singh (DIN: 08453794) from Rs. 75000.00 per month to Rs. 200000.00 per month. 8. Increase in remuneration of Mr. Harendra Singh (PAN: BANPS9243R) from Rs. 2.25 lakh to Rs. 3.5 lakh per month.
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.